Chopra M. Anmol

Learn More
Lateral flow immunoassay (LFIA) platform is one of the most relevant technologies for screening and diagnosing clinical conditions [1]. However due to low sensitivity and poor repeatability of the platform it has been used only for limited and non-critical tests [2] [5]. Mathematical models have been used to understand the principles of capillary flow and(More)
  • 1